The budgetary allocation to artificial intelligence and machine learning in the healthcare sector is expected to reach 10.5% in 2024, up from 5.5% in 2022, Morgan Stanley said in a recent research report, citing industry-specific implications of the rapidly evolving field.
Fueled by the arrival of OpenAI’s ChatGPT, artificial intelligence is making waves across Wall Street, leading to sky-high valuations in chipmakers. Even biopharma firms with AI connections have benefited.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased